Literature DB >> 18046079

A comparative evaluation of various methods for microalbuminuria screening.

Pantelis A Sarafidis1, Jessica Riehle, Zvezdana Bogojevic, Emad Basta, Atul Chugh, George L Bakris.   

Abstract

BACKGROUND/AIMS: Microalbuminuria is a marker of abnormal vascular response and a predictor of cardiovascular morbidity and mortality. We evaluated a new quantitative office-based method to assess urinary albumin excretion (UAE) and compared it to other established methods.
METHODS: Spot urine samples from 165 patients were analyzed at a single study site using the HemoCue system, Clinitek Microalbumin, and Chemstrip Micral test, as well as at a central laboratory, where UAE and creatinine levels were measured. The central laboratory UAE values were used as reference. We evaluated the validity of the HemoCue results and compared them to the respective data for the laboratory albumin-to-creatinine ratio (ACR). Additionally, we assessed, diagnostic sensitivity, specificity, and positive and negative predictive values of all four methods, as well as the reproducibility of the HemoCue measurements.
RESULTS: Linear regression analysis demonstrated a good correlation for the HemoCue system (y = 0.9978x - 1.0217, R2 = 0.904) and ACR (y = 0.0815x + 0.3373, R2 = 0.784). Sensitivity and specificity for microalbuminuria diagnosis were 92 and 98% for HemoCue, 73 and 96% for ACR, 100 and 81% for Clinitek Microalbumin, and 70 and 83% for Chemstrip Micral dipstick, respectively. The correlation coefficient of duplicate HemoCue measurements was r = 0.98 (p < 0.001).
CONCLUSIONS: The HemoCue system for microalbuminuria detection was as accurate and precise as laboratory ACR estimations. Its diagnostic performance was much better than that of widely used dipstick methods. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046079     DOI: 10.1159/000111825

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  12 in total

1.  Cost-effectiveness of screening for microalbuminuria among African Americans.

Authors:  Thomas J Hoerger; John S Wittenborn; Xiaohui Zhuo; Meda E Pavkov; Nilka R Burrows; Paul Eggers; Regina Jordan; Sharon Saydah; Desmond E Williams
Journal:  J Am Soc Nephrol       Date:  2012-12       Impact factor: 10.121

2.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

3.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

Authors:  Allison E Ashley-Koch; Emmanuel C Okocha; Melanie E Garrett; Karen Soldano; Laura M De Castro; Jude C Jonassaint; Eugene P Orringer; James R Eckman; Marilyn J Telen
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

4.  Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).

Authors:  Carmen A Peralta; Keith C Norris; Suying Li; Tara I Chang; Manjula K Tamura; Stacey E Jolly; George Bakris; Peter A McCullough; Michael Shlipak
Journal:  Arch Intern Med       Date:  2012-01-09

5.  A Comparative Study of Clinical Utility of Spot Urine Samples with 24-h Urine Albumin Excretion for Screening of Microalbuminuria in Type 2 Diabetic Patients.

Authors:  Vilas U Chavan; Pushpa P Durgawale; Anjum K Sayyed; Ajit V Sontakke; Nazir R Attar; Swati B Patel; Sangita R Patil; Shreyasprasad D Nilakhe
Journal:  Indian J Clin Biochem       Date:  2011-04-30

6.  Screening for CKD with eGFR: doubts and dangers.

Authors:  Richard J Glassock; Christopher Winearls
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

7.  Effectiveness and tolerability of a trandolapril-based antihypertensive treatment regimen over 12 months in actual clinical care across Canada.

Authors:  Richard Tytus; Ellen Burgess; Julia Maurer; Anita Vanjaka
Journal:  Clin Drug Investig       Date:  2013-08       Impact factor: 2.859

8.  Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12).

Authors:  Padmaja K Rani; Rajiv Raman; Aditi Gupta; Swakshyar S Pal; Vaitheeswaran Kulothungan; Tarun Sharma
Journal:  Diabetol Metab Syndr       Date:  2011-05-25       Impact factor: 3.320

9.  Screening for Nephropathy in Diabetes Mellitus: Is Micral-Test Valid among All Diabetics?

Authors:  Koubaa Afifa; Sriha Belguith Asma; Harzallah Nabil; Bellaleh Ahlem; Sahtout Mounira; Younes Kawthar; Triki Sonia; Hellara Ilhem; Neffati Fadoua; Najjar Fadhel; Soltani Mohamed
Journal:  Int J Chronic Dis       Date:  2016-05-18

10.  Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study.

Authors:  Heba Alwan; Menno Pruijm; Belen Ponte; Daniel Ackermann; Idris Guessous; Georg Ehret; Jan A Staessen; Kei Asayama; Philippe Vuistiner; Sandrine Estoppey Younes; Fred Paccaud; Grégoire Wuerzner; Antoinette Pechere-Bertschi; Markus Mohaupt; Bruno Vogt; Pierre-Yves Martin; Michel Burnier; Murielle Bochud
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.